IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—29 July 2014

1:30 AM MDT | July 29, 2014 | Deepti Ramesh

Lonza reports huge rise in profits Lonza recorded net profits of 140 million Swiss francs ($155 million) for the first half of 2014 compared with profits of SF41 million in the first half of 2013. Sales for the first half of 2014 increased by 3.2% compared with the year-ago period, to SF1.80 billion. In the first half of 2014, Lonza’s specialty ingredients and pharma and biotech market segments both delivered a sound performance despite currency headwinds and are fully on track to deliver the growth targets, Lonza says. The sales growth of 3.2% and core...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa